gamma-aminobutyric acid has been researched along with Intraocular Pressure in 14 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Intraocular Pressure: The pressure of the fluids in the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We explored the melatonin influence on the level of amino acid neurotransmitters of the retina in glaucoma neuropathy in rats." | 7.79 | [Protective action of melatonin in experimental glaucoma in rats]. ( Mykheĭtseva, IM, 2013) |
| "Gabapentin is an antiepileptic drug widely approved as an add-on therapy for epilepsy treatment in human and dogs." | 6.84 | Effects of premedication with oral gabapentin on intraocular pressure changes following tracheal intubation in clinically normal dogs. ( Capik, I; Ghaffari, MS; Trbolova, A, 2017) |
| "Gabapentin has been used effectively to attenuate the pressor response to laryngoscopy and tracheal intubation." | 6.73 | Effect of oral gabapentin on the intraocular pressure and haemodynamic responses induced by tracheal intubation. ( Altun, GT; Ata, F; Baykara, M; Gülhan, N; Kaya, FN; Yavascaoglu, B, 2008) |
| "Glaucoma was caused by the prolong systemic introduction of adrenalin." | 5.39 | [Protective action of melatonin in experimental glaucoma in rats]. ( Mykheĭtseva, IM, 2013) |
| "Glaucoma is a leading cause of blindness." | 5.36 | Melatonin: a novel neuroprotectant for the treatment of glaucoma. ( Belforte, NA; Chianelli, MS; de Zavalía, N; Keller Sarmiento, MI; Moreno, MC; Rosenstein, RE; Sande, PH, 2010) |
| " This study aims to determine variations in the levels of L-glutamate and γ-aminobutyric acid (GABA), histaminergic, adrenergic, cholinergic, and serotonergic NTs in patients with primary glaucoma versus patients with cataract." | 4.02 | Elevated histamine levels in aqueous humor of patients with glaucoma. ( Angmo, D; Dada, T; Gowtham, L; Halder, N; Jayasundar, R; Singh, SB; Velpandian, T, 2021) |
| "We explored the melatonin influence on the level of amino acid neurotransmitters of the retina in glaucoma neuropathy in rats." | 3.79 | [Protective action of melatonin in experimental glaucoma in rats]. ( Mykheĭtseva, IM, 2013) |
| "Amacrine cells identified by GABA and glycine labeling were not significantly affected by experimental glaucoma, with a mean decrease of 15% compared with bilaterally untreated control cells (557 +/- 186 neurons/mm [glaucoma] versus 653." | 3.73 | The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. ( Kielczewski, JL; Pease, ME; Quigley, HA, 2005) |
| "An inner retinal component removed by GABA and glycine was found in both the normal and glaucomatous eyes." | 3.72 | Functional damage to inner and outer retinal cells in experimental glaucoma. ( Lambrou, GN; Ofri, R; Percicot, CL; Perlman, I; Raz, D, 2003) |
| "25% betaxolol) in the rat retina following the ischemic injury induced by a transient increase of intraocular pressure (IOP)." | 3.71 | Betaxolol, a beta1-adrenoceptor antagonist, protects a transient ischemic injury of the retina. ( Hee Kim, Y; Jae Cho, G; Joon Kim, H; Kyung Song, J; Myong Yoo, J; Soo Kang, S; Sung Choi, W; Woo Cheon, E; Yun Cho, Y, 2002) |
| "Gabapentin is an antiepileptic drug widely approved as an add-on therapy for epilepsy treatment in human and dogs." | 2.84 | Effects of premedication with oral gabapentin on intraocular pressure changes following tracheal intubation in clinically normal dogs. ( Capik, I; Ghaffari, MS; Trbolova, A, 2017) |
| "Gabapentin has been used effectively to attenuate the pressor response to laryngoscopy and tracheal intubation." | 2.73 | Effect of oral gabapentin on the intraocular pressure and haemodynamic responses induced by tracheal intubation. ( Altun, GT; Ata, F; Baykara, M; Gülhan, N; Kaya, FN; Yavascaoglu, B, 2008) |
| "Glaucoma is a leading cause of irreversible blindness worldwide, and increased intraocular pressure (IOP) is a major risk factor." | 1.62 | Early Functional Impairment in Experimental Glaucoma Is Accompanied by Disruption of the GABAergic System and Inceptive Neuroinflammation. ( Elwood, BW; Godwin, CR; Gramlich, OW; Kuehn, MH; Wadkins, D, 2021) |
| "Glaucoma was caused by the prolong systemic introduction of adrenalin." | 1.39 | [Protective action of melatonin in experimental glaucoma in rats]. ( Mykheĭtseva, IM, 2013) |
| "Glaucoma is a leading cause of blindness." | 1.36 | Melatonin: a novel neuroprotectant for the treatment of glaucoma. ( Belforte, NA; Chianelli, MS; de Zavalía, N; Keller Sarmiento, MI; Moreno, MC; Rosenstein, RE; Sande, PH, 2010) |
| "Complete optic nerve transection was performed unilaterally in nine rats with survival for 1 (n = 4) and 3 (n = 5) months." | 1.33 | The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. ( Kielczewski, JL; Pease, ME; Quigley, HA, 2005) |
| "Ischemia was induced in the rat retina by raising the IOP above the systolic blood pressure for 60min." | 1.31 | Betaxolol, a beta1-adrenoceptor antagonist, protects a transient ischemic injury of the retina. ( Hee Kim, Y; Jae Cho, G; Joon Kim, H; Kyung Song, J; Myong Yoo, J; Soo Kang, S; Sung Choi, W; Woo Cheon, E; Yun Cho, Y, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gowtham, L | 1 |
| Halder, N | 1 |
| Angmo, D | 1 |
| Singh, SB | 1 |
| Jayasundar, R | 1 |
| Dada, T | 1 |
| Velpandian, T | 1 |
| Gramlich, OW | 1 |
| Godwin, CR | 1 |
| Wadkins, D | 1 |
| Elwood, BW | 1 |
| Kuehn, MH | 1 |
| Trbolova, A | 1 |
| Ghaffari, MS | 1 |
| Capik, I | 1 |
| Kavitha, J | 1 |
| Parida, S | 1 |
| Kundra, P | 1 |
| Srinivasan, R | 1 |
| Mykheĭtseva, IM | 1 |
| Bailey, JN | 1 |
| Yaspan, BL | 1 |
| Pasquale, LR | 1 |
| Hauser, MA | 1 |
| Kang, JH | 1 |
| Loomis, SJ | 1 |
| Brilliant, M | 1 |
| Budenz, DL | 1 |
| Christen, WG | 1 |
| Fingert, J | 1 |
| Gaasterland, D | 1 |
| Gaasterland, T | 1 |
| Kraft, P | 1 |
| Lee, RK | 1 |
| Lichter, PR | 1 |
| Liu, Y | 1 |
| McCarty, CA | 1 |
| Moroi, SE | 1 |
| Richards, JE | 1 |
| Realini, T | 1 |
| Schuman, JS | 1 |
| Scott, WK | 1 |
| Singh, K | 1 |
| Sit, AJ | 1 |
| Vollrath, D | 1 |
| Wollstein, G | 1 |
| Zack, DJ | 1 |
| Zhang, K | 1 |
| Pericak-Vance, MA | 1 |
| Allingham, RR | 1 |
| Weinreb, RN | 1 |
| Haines, JL | 1 |
| Wiggs, JL | 1 |
| Kaya, FN | 1 |
| Yavascaoglu, B | 1 |
| Baykara, M | 1 |
| Altun, GT | 1 |
| Gülhan, N | 1 |
| Ata, F | 1 |
| Belforte, NA | 1 |
| Moreno, MC | 1 |
| de Zavalía, N | 1 |
| Sande, PH | 1 |
| Chianelli, MS | 1 |
| Keller Sarmiento, MI | 1 |
| Rosenstein, RE | 1 |
| Woo Cheon, E | 1 |
| Hee Kim, Y | 1 |
| Yun Cho, Y | 1 |
| Joon Kim, H | 1 |
| Soo Kang, S | 1 |
| Jae Cho, G | 1 |
| Myong Yoo, J | 1 |
| Kyung Song, J | 1 |
| Sung Choi, W | 1 |
| Raz, D | 1 |
| Perlman, I | 1 |
| Percicot, CL | 1 |
| Lambrou, GN | 1 |
| Ofri, R | 1 |
| Kielczewski, JL | 1 |
| Pease, ME | 1 |
| Quigley, HA | 1 |
| Osborne, NN | 1 |
| Herrera, AJ | 1 |
| Perlman, JI | 1 |
| McCole, SM | 1 |
| Pulluru, P | 1 |
| Chang, CJ | 1 |
| Lam, TT | 1 |
| Tso, MO | 1 |
| Mincione, G | 1 |
| Menabuoni, L | 1 |
| Briganti, F | 1 |
| Mincione, F | 1 |
| Scozzafava, A | 1 |
| Supuran, CT | 1 |
3 trials available for gamma-aminobutyric acid and Intraocular Pressure
| Article | Year |
|---|---|
Effects of premedication with oral gabapentin on intraocular pressure changes following tracheal intubation in clinically normal dogs.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Dogs; Gabapentin; gamma-Aminobutyric Acid; | 2017 |
Oral gabapentin premedication for elderly patients undergoing intraocular surgery.
Topics: Administration, Oral; Amines; Analgesics; Anesthesia, Conduction; Anti-Anxiety Agents; Blood Pressur | 2013 |
Effect of oral gabapentin on the intraocular pressure and haemodynamic responses induced by tracheal intubation.
Topics: Administration, Oral; Adult; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobut | 2008 |
11 other studies available for gamma-aminobutyric acid and Intraocular Pressure
| Article | Year |
|---|---|
Elevated histamine levels in aqueous humor of patients with glaucoma.
Topics: Adult; Aged; Aqueous Humor; Case-Control Studies; Cataract; Chromatography, Liquid; Female; gamma-Am | 2021 |
Early Functional Impairment in Experimental Glaucoma Is Accompanied by Disruption of the GABAergic System and Inceptive Neuroinflammation.
Topics: Animals; Cytoskeletal Proteins; Disease Models, Animal; Eye Proteins; Female; GABAergic Neurons; gam | 2021 |
[Protective action of melatonin in experimental glaucoma in rats].
Topics: Animals; Antioxidants; Aspartic Acid; Chromatography, Ion Exchange; Epinephrine; gamma-Aminobutyric | 2013 |
Hypothesis-independent pathway analysis implicates GABA and acetyl-CoA metabolism in primary open-angle glaucoma and normal-pressure glaucoma.
Topics: Acetyl Coenzyme A; Case-Control Studies; Cluster Analysis; Female; gamma-Aminobutyric Acid; Genetic | 2014 |
Melatonin: a novel neuroprotectant for the treatment of glaucoma.
Topics: Animals; Arginine; gamma-Aminobutyric Acid; Glaucoma; Glutamate Decarboxylase; Glutamic Acid; Histoc | 2010 |
Betaxolol, a beta1-adrenoceptor antagonist, protects a transient ischemic injury of the retina.
Topics: Animals; Antihypertensive Agents; Betaxolol; Choline O-Acetyltransferase; gamma-Aminobutyric Acid; I | 2002 |
Functional damage to inner and outer retinal cells in experimental glaucoma.
Topics: Aminobutyrates; Animals; Electroretinography; gamma-Aminobutyric Acid; Glaucoma; Glycine; Interneuro | 2003 |
The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina.
Topics: Amacrine Cells; Animals; Axons; Cell Count; Disease Models, Animal; gamma-Aminobutyric Acid; Glaucom | 2005 |
The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amin | 1994 |
Disturbances in the distribution of neurotransmitters in the rat retina after ischemia.
Topics: Animals; gamma-Aminobutyric Acid; Glutamic Acid; Immunohistochemistry; Intraocular Pressure; Ischemi | 1996 |
Carbonic anhydrase inhibitors. Part 79. Synthesis of topically acting sulfonamides incorporating GABA moieties in their molecule, with long-lasting intraocular pressure-lowering properties.
Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Cell Membrane; Cornea; Cytosol; Dis | 1999 |